Search Login Register

deferasirox Summary

Description: for the treatment of chronic iron overload from blood transfusions

Also Known As: 4-(3,5-bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid; Exjade; ICL 670; ICL 670A; ICL-670 Show All >>

Networked: 391 relevant articles (72 outcomes, 94 trials/studies) for this Drug

Key Diseases for which deferasirox is Relevant

  1. Iron Overload : 29 outcomes 35 studies in 193 results
  2. beta-Thalassemia (Cooley's Anemia) : 10 outcomes 19 studies in 78 results
  3. Thalassemia : 10 outcomes 17 studies in 49 results
  4. Myelodysplastic Syndromes (Myelodysplastic Syndrome) : 8 outcomes 18 studies in 55 results
  5. Anemia : 6 outcomes 6 studies in 27 results
Show All >>

Drugs Related to deferasirox

  1. Iron
  2. deferasirox
  3. Deferoxamine (Desferal)
  4. deferiprone (CP20)
  5. liposomal amphotericin B
  6. Ferritins (Ferritin)
  7. Chelating Agents
  8. caspofungin (Cancidas)
  9. Hemoglobins (Hemoglobin)
  10. Iron Chelating Agents
Show All >>

Therapies Related to deferasirox

  1. Chelation Therapy (Therapy, Chelation)
  2. Drug Therapy (Chemotherapy)
  3. Blood Transfusion (Blood Transfusions)
  4. Transplantation (Transplant Recipients)
  5. Stents
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.